De-Risking Drug Discovery with Applied BioMath Assess™, a New Early Feasibility Assessment Tool for Biotherapeutics
The steep cost of developing a new therapeutic to market. Early feasibility assessment (EFA) has proven to drastically improve the efficiency of pharmaceutical R&D and should be integrated into every drug R&D program. Applied BioMath Assess*, a new web-based application that provides the necessary models and analyses via an intuitive interface, makes this integration a reality.

*Patent pending